aspect of
drug)
→
ReceivesAction
→
maintained in long-term follow-up studies
| Typicality: | 0.270 |
| Saliency: | 0.049 |
| without placebo control | 4 | other |
| effect → be maintained in → long-term follow-up studies | 4 |
| negative | neutral | positive |
| 0.008 | 0.743 | 0.249 |
| Raw frequency | 4 |
| Normalized frequency | 0.049 |
| Modifier score | 0.500 |
| Perplexity | 27.238 |